Rantac Dom Tablets contain the active component Ranitidine and Domperidone. Ranitidine reduces stomach acid production as an H2 blocker. It can help relieve symptoms associated with conditions such as peptic ulcers, GERD, and Zollinger-Ellison syndrome. Zollinger-Ellison syndrome is a rare condition that causes excessive acid production in the stomach, leading to peptic ulcers. GERD is characterized by the backward flow of stomach acid into the esophagus, causing heartburn and acid reflux. By decreasing acid production, ranitidine can alleviate heartburn, indigestion, and stomach pain. As a dopamine receptor antagonist, Domperidone improves gastrointestinal motility and helps prevent nausea and vomiting. It is commonly used for gastroparesis, which involves delayed gastric emptying.

Individuals with known hypersensitivity or allergy to Rantac Dom Tablets or any components should not use these medications. Certain individuals may have specific medical conditions or factors that increase the risk of adverse effects when combining Rantac Dom Tablets. These factors may include a history of cardiac arrhythmias, electrolyte imbalances, or gastrointestinal bleeding. These medications are excreted through the kidneys, and their use may require adjustment in individuals with kidney dysfunction. Elderly individuals are more susceptible to the side effects, such as confusion, dizziness, and cardiac effects. Close monitoring and dosage adjustments are necessary in this population to minimize the risk of adverse effects.

• Peptic ulcers
• Gastroesophageal reflux disease
• Zollinger-Ellison syndrome
• Nausea and vomiting
• Gastroparesis

By reducing stomach acid production with ranitidine, the potential irritation and discomfort caused by excess acid can be minimized. Domperidone then complements the effects of ranitidine by improving gastrointestinal motility, allowing for better digestion, and preventing symptoms like nausea and vomiting.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Rantac Dom Tablets, reducing effectiveness by causing undesirable side effects.

• Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

A healthcare provider typically prescribes Rantac Dom Tablets. This medication is usually taken orally once a day, with or without food. Use recommended dosage, which may vary depending on the specific product and individual needs. It is important to adhere to the suggested frequency and timing of the intake.

Rantac Dom Tablets cause some side effects like all medications, although not everyone will experience them. 

Serious:

• Allergic reactions (hives, difficulty breathing, swelling of the face or throat)
• Severe stomach pain
• Yellowing of the skin or eyes (jaundice)
• Unusual bleeding or bruising
• Rapid or irregular heartbeat
• Chest pain
• Severe skin reactions (Stevens-Johnson syndrome)
• Mood changes (confusion, hallucinations)

Common:

• Headache
• Dizziness
• Diarrhea
• Nausea
• Abdominal pain
• Constipation
• Fatigue
• Rash or itching

Regarding your health and medication usage, it is important to prioritize open communication with your healthcare provider. Make sure to provide them with a comprehensive overview of your medical history, including any existing conditions, medications you are currently taking, or any allergies you may have. Breastfeeding and pregnant women should discuss this with their healthcare provider before using it. It should be used cautiously in individuals with Parkinson's disease and avoided in gastrointestinal bleeding or obstruction cases. Follow the doctor's instructions regarding dosage, frequency, and duration of medication use. If you experience any unexpected or concerning symptoms while taking Rantac dom Tablets, or any other medications, don't hesitate to contact your healthcare provider for guidance.

1. Aurobindo Pharma, Electronic medicines compendium (EMC), [Revised on 15 April 2021], [Accessed on 3rd June 2023], https://www.medicines.org.uk/emc/product/556/smpc#gref
2. GlaxoSmithKline, US Food and Drug Administration, [Revised on April 2009],[Accessed on 3rd June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018703s068,019675s035,020251s019lbl.pdf